Target intelligence / Profile preview

RNA-binding motif protein 14 (RBM14)

Target
RBM14
Molecular classification
RNA-binding protein, Transcription coactivator, Alternative splicing modulator, Other (paraspeckle protein)
01

Overview

RNA-binding motif protein 14 (RBM14) is a nuclear RNA-binding protein that possesses two RNA recognition motifs and multiple C-terminal hexapeptide repeats. It acts as a transcriptional coactivator and alternative splicing regulator, modulating nuclear hormone receptor activity and gene expression. RBM14 plays important roles in DNA damage response, especially in recruiting repair factors to double-strand break (DSB) sites and facilitating non-homologous end joining (NHEJ). It is also involved in the regulation of pre-mRNA splicing, mitotic spindle assembly, and the innate immune response via the cGAS-STING pathway. Dysregulation of RBM14 has been implicated in cancer progression (e.g., glioblastoma, osteosarcoma), cellular radioresistance, and certain neurodegenerative and ocular diseases[1][2][4][5][7].

Other names
RNA-binding protein 14SIPPSP2SYT-interacting proteinSYTIP1COAAParaspeckle protein 2RRM-containing coactivator activator/modulatorSynaptotagmin-interacting proteinCoactivator activatorTransmembrane protein 137RBM14-RBM4 (context: read-through transcript)
02

Mechanism of action

Not established for specific drugs as of the current evidence. Small molecules or oligonucleotides modifying RNA-binding or splicing may be conceptually possible, but no specific RBM14-targeted agents are described as of now.

03

Biological functions

Transcriptional regulation (including acting as a nuclear receptor coactivator)RNA splicing modulationDNA damage response (recruitment to DNA double-strand breaks, DNA repair via non-homologous end joining)Centriole biogenesis and mitotic spindle integrityInnate immune response (cGAS-STING pathway)Cell proliferation and migration
04

Disease associations

Cancer (including glioblastoma multiforme and osteosarcoma)Neurodegenerative disease (spinal muscular atrophy with progressive myoclonic epilepsy)Marginal corneal ulcerOther (radio-resistance in tumors)
05

Safety considerations

Potential therapeutic targeting could theoretically disrupt essential DNA repair and alternative splicing, leading to genome instability or defective cell division.Broad inhibition could interfere with normal stem cell maintenance, differentiation, or immune responses.
06

Biomarkers

Increased RBM14 expression may serve as a marker for radioresistance and poor differentiation in glioblastomaHigh RBM14 levels are associated with markers of proliferation and malignancy in osteosarcoma

Beyond the preview

Go deeper on RNA-binding motif protein 14 (RBM14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-binding motif protein 14 (RBM14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call